Duloxetine

Product NDC: 68788-8362
11-digit product format: 687888362
Labeler code: 68788
Product ID: 68788-8362_19b034a2-26d7-4c9b-b8a6-391e06a31adb
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: DULOXETINE HYDROCHLORIDE
Dosage form: CAPSULE, DELAYED RELEASE PELLETS
Route: ORAL
Labeler: Preferred Pharmaceuticals Inc.
Application: ANDA203088
Marketing category: ANDA
Marketing start: 2023-02-01
Substance: DULOXETINE HYDROCHLORIDE
Active strength: 40 mg/1
Pharmacologic classes: Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	68788-8362	68788-8362-6	D	Discontinued by firm		2026-10-16

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A203088-001	DULOXETINE HYDROCHLORIDE	DULOXETINE HYDROCHLORIDE	EQ 20MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2014-06-11
A203088-002	DULOXETINE HYDROCHLORIDE	DULOXETINE HYDROCHLORIDE	EQ 30MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2014-06-11
A203088-003	DULOXETINE HYDROCHLORIDE	DULOXETINE HYDROCHLORIDE	EQ 60MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2014-06-11
A203088-004	DULOXETINE HYDROCHLORIDE	DULOXETINE HYDROCHLORIDE	EQ 40MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2018-05-18

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-product	TE code
A203088-001	AB
A203088-002	AB
A203088-003	AB
A203088-004	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 176 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-10-15 13:18:30	2026-09	A203088-001	DULOXETINE HYDROCHLORIDE	EQ 20MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2014-06-11	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A203088-002	DULOXETINE HYDROCHLORIDE	EQ 30MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2014-06-11	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A203088-003	DULOXETINE HYDROCHLORIDE	EQ 60MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2014-06-11	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A203088-004	DULOXETINE HYDROCHLORIDE	EQ 40MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2018-05-18	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	A203088-001	DULOXETINE HYDROCHLORIDE	EQ 20MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2014-06-11	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A203088-002	DULOXETINE HYDROCHLORIDE	EQ 30MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2014-06-11	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A203088-003	DULOXETINE HYDROCHLORIDE	EQ 60MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2014-06-11	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A203088-004	DULOXETINE HYDROCHLORIDE	EQ 40MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2018-05-18	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A203088-001	DULOXETINE HYDROCHLORIDE	EQ 20MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2014-06-11	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203088-002	DULOXETINE HYDROCHLORIDE	EQ 30MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2014-06-11	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203088-003	DULOXETINE HYDROCHLORIDE	EQ 60MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2014-06-11	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203088-004	DULOXETINE HYDROCHLORIDE	EQ 40MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2018-05-18	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A203088-001	DULOXETINE HYDROCHLORIDE	EQ 20MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2014-06-11	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203088-002	DULOXETINE HYDROCHLORIDE	EQ 30MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2014-06-11	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203088-003	DULOXETINE HYDROCHLORIDE	EQ 60MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2014-06-11	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203088-004	DULOXETINE HYDROCHLORIDE	EQ 40MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2018-05-18	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203088-001	DULOXETINE HYDROCHLORIDE	EQ 20MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2014-06-11	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203088-002	DULOXETINE HYDROCHLORIDE	EQ 30MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2014-06-11	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203088-003	DULOXETINE HYDROCHLORIDE	EQ 60MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2014-06-11	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203088-004	DULOXETINE HYDROCHLORIDE	EQ 40MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2018-05-18	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A203088-001	DULOXETINE HYDROCHLORIDE	EQ 20MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2014-06-11	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203088-002	DULOXETINE HYDROCHLORIDE	EQ 30MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2014-06-11	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203088-003	DULOXETINE HYDROCHLORIDE	EQ 60MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2014-06-11	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203088-004	DULOXETINE HYDROCHLORIDE	EQ 40MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2018-05-18	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203088-001	DULOXETINE HYDROCHLORIDE	EQ 20MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2014-06-11	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203088-002	DULOXETINE HYDROCHLORIDE	EQ 30MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2014-06-11	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203088-003	DULOXETINE HYDROCHLORIDE	EQ 60MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2014-06-11	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203088-004	DULOXETINE HYDROCHLORIDE	EQ 40MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2018-05-18	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203088-001	DULOXETINE HYDROCHLORIDE	EQ 20MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2014-06-11	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203088-002	DULOXETINE HYDROCHLORIDE	EQ 30MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2014-06-11	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203088-003	DULOXETINE HYDROCHLORIDE	EQ 60MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2014-06-11	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203088-004	DULOXETINE HYDROCHLORIDE	EQ 40MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2018-05-18	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203088-001	DULOXETINE HYDROCHLORIDE	EQ 20MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2014-06-11	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203088-002	DULOXETINE HYDROCHLORIDE	EQ 30MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2014-06-11	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203088-003	DULOXETINE HYDROCHLORIDE	EQ 60MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2014-06-11	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203088-004	DULOXETINE HYDROCHLORIDE	EQ 40MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2018-05-18	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203088-001	DULOXETINE HYDROCHLORIDE	EQ 20MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2014-06-11	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203088-002	DULOXETINE HYDROCHLORIDE	EQ 30MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2014-06-11	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203088-003	DULOXETINE HYDROCHLORIDE	EQ 60MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2014-06-11	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203088-004	DULOXETINE HYDROCHLORIDE	EQ 40MG BASE	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2018-05-18	`2680178bc6a6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 5 · 176 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-10-15 13:18:30	2026-09	A203088-001	AB	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A203088-002	AB	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A203088-003	AB	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A203088-004	AB	1	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	A203088-001	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A203088-002	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A203088-003	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A203088-004	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A203088-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203088-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203088-003	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203088-004	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A203088-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203088-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203088-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203088-004	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203088-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203088-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203088-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203088-004	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A203088-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203088-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203088-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203088-004	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203088-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203088-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203088-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203088-004	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203088-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203088-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203088-003	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203088-004	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203088-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203088-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203088-003	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203088-004	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203088-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203088-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203088-003	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203088-004	AB	1	`2680178bc6a6…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Duloxetine
Brand name suffix: Delayed-Release
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
DULOXETINE HYDROCHLORIDE	40 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
9044SC542W	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
616402	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
2c233b3f-83de-40c4-9f1d-81f901f89459	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
aebfdb62-b550-4c4f-9225-d5d3bbc7ab88	Product name	9	20210727
7dd29e28-6b69-499b-9257-12a3b46ca283	Product name	1	20191120

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
68788-8362-0	DuloxetineDelayed-Release	60 in 1 BOTTLE	CAPSULE, DELAYED RELEASE PELLETS	60	5
68788-8362-3	DuloxetineDelayed-Release	30 in 1 BOTTLE	CAPSULE, DELAYED RELEASE PELLETS	30	5
68788-8362-6	DuloxetineDelayed-Release	63 in 1 BOTTLE	CAPSULE, DELAYED RELEASE PELLETS	63	5
68788-8362-9	DuloxetineDelayed-Release	90 in 1 BOTTLE	CAPSULE, DELAYED RELEASE PELLETS	90	5

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
68788-8362-0	EA - Each	68788-8362	e0eec225-a064-4a94-8dda-bbde3f866f7f	1	2023-04-07
68788-8362-3	EA - Each	68788-8362	c20c4b86-7686-44ed-8464-3c9d5cb7f347	1	2023-03-13
68788-8362-6	EA - Each	68788-8362	17e2ee2a-e9f5-4c73-af2e-cadc31dc2f48	1	2023-03-13
68788-8362-9	EA - Each	68788-8362	543119f7-ba95-4fc1-82e1-35b0115fa353	1	2023-03-13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68788-8362	DULOXETINE DELAYED-RELEASE (DULOXETINE HYDROCHLORIDE) CAPSULE, DELAYED RELEASE PELLETS [PREFERRED PHARMACEUTICALS INC.]	5	Current NDC, 4 package rows	20250406_2c233b3f-83de-40c4-9f1d-81f901f89459.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 2 · 29 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Duloxetine Delayed-Release	DULOXETINE HYDROCHLORIDE	Bryant Ranch Prepack	675f999d-46b2-45da-b17e-58cc2ba180b1	2024-04-02	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203088 application number: ANDA203088
Duloxetine Delayed-Release	DULOXETINE HYDROCHLORIDE	Aphena Pharma Solutions - Tennessee, LLC	b1f1345c-3b7f-4228-b7b7-b9a4648050e5	2024-03-28	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203088 application number: ANDA203088
Duloxetine Delayed-Release	DULOXETINE HYDROCHLORIDE	BluePoint Laboratories	a95cc04c-58e9-487f-8992-ef30df03a3cd	2024-02-14	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203088 application number: ANDA203088
DULOXETINE DELAYED-RELEASE	DULOXETINE HYDROCHLORIDE	Proficient Rx LP	41c86c02-68c0-4db5-af1a-941b0d2ffe11	2024-02-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203088 application number: ANDA203088
Duloxetine Delayed-Release	DULOXETINE HYDROCHLORIDE	Proficient Rx LP	f5e7503a-b28f-4cd0-a4ee-47bdca88d54b	2023-10-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203088 application number: ANDA203088
Duloxetine Delayed-Release	DULOXETINE HYDROCHLORIDE	Aphena Pharma Solutions - Tennessee, LLC	dcfd62c7-1687-4e9b-9ae4-5a44929ac765	2023-09-15	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203088 application number: ANDA203088
DULOXETINE DELAYED-RELEASE	DULOXETINE HYDROCHLORIDE	Proficient Rx LP	22a8cc15-17fb-4c4e-8d2a-de5755ed6031	2022-10-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203088 application number: ANDA203088
DULOXETINE DELAYED-RELEASE	DULOXETINE HYDROCHLORIDE	Proficient Rx LP	407b62b9-5b32-4bac-a2b0-7df499279248	2019-11-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203088 application number: ANDA203088
Duloxetine Delayed-Release	DULOXETINE HYDROCHLORIDE	Aphena Pharma Solutions - Tennessee, LLC	db686a0a-9b2a-4017-8bd1-b981da47c2f3	2019-01-11	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203088 application number: ANDA203088

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
9044SC542W	DULOXETINE HYDROCHLORIDE	136434-34-9	DULOXETINE HYDROCHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
616402	DULoxetine 40 MG Delayed Release Oral Capsule	PSN	2c233b3f-83de-40c4-9f1d-81f901f89459	5
616402	duloxetine 40 MG Delayed Release Oral Capsule	SCD	2c233b3f-83de-40c4-9f1d-81f901f89459	5
616402	duloxetine 40 MG (as duloxetine HCl 44.9 MG) Delayed Release Oral Capsule	SY	2c233b3f-83de-40c4-9f1d-81f901f89459	5

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Sample	Exclude flag	Status
68788-8362-0	68788836200	60 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (68788-8362-0)	2023-03-14	No	No	Current
68788-8362-3	68788836203	30 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (68788-8362-3)	2023-02-01	No	No	Current
68788-8362-6	68788836206	63 in 1 BOTTLE				Historical
68788-8362-9	68788836209	90 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (68788-8362-9)	2023-02-01	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Duloxetine Delayed-Release	Preferred Pharmaceuticals Inc.	2025-04-04	HUMAN PRESCRIPTION DRUG LABEL	5